BIOSYNTHESIS OF SELENIUM NANOPARTICLES BY A PROCESS OF REDUCTION USING A FUNGAL STAIN OF ASPERGILLUS ORYZAE AND THEIR VITRO ANTICANCER ACTIVITY HUMAN BREAST CANCER CELL LINE MDA MB-435) AS WELL AS ALTERATION OF BOVIN SERUM ALBUMIN ENVIRONMENT

摘要

The present invention relates to novel synthesis of selenium nanoparticles using fungal strains of from Aspergillus oryzae. The main objectives of the present invention are to study the anticancer activity of these selenium nanoparticles on human breast cancer cell line MDA MB-435 and to study their interaction with bovine serum albumin protein